Invention Grant
US08765695B2 Use of ginsenoside RG1, its metabolites ginsenoside RH1 and/or PPT
有权
使用人参皂苷RG1，其代谢物人参皂甙RH1和/或PPT
- Patent Title: Use of ginsenoside RG1, its metabolites ginsenoside RH1 and/or PPT
- Patent Title (中): 使用人参皂苷RG1，其代谢物人参皂甙RH1和/或PPT
-
Application No.: US12530970Application Date: 2007-12-25
-
Publication No.: US08765695B2Publication Date: 2014-07-01
- Inventor: Juntian Zhang , Shifeng Chu
- Applicant: Juntian Zhang , Shifeng Chu
- Applicant Address: CN Yunnan CN Yunnan
- Assignee: Jecui Health Industry Corp. Ltd.,Institute of Materia Medica, Chinese Academy of Medical Sciences
- Current Assignee: Jecui Health Industry Corp. Ltd.,Institute of Materia Medica, Chinese Academy of Medical Sciences
- Current Assignee Address: CN Yunnan CN Yunnan
- Agency: Brinks Gilson & Lione
- International Application: PCT/CN2007/003776 WO 20071225
- International Announcement: WO2008/110050 WO 20080918
- Main IPC: C07J41/00
- IPC: C07J41/00 ; A01N45/00
Abstract:
The present invention relates to use of an active ingredient selected from ginsenoside Rg1, its metabolites ginsenoside Rh1 and Ppt for preparing a medicament and a health care product for improving sexual function of male mammals, and for providing the effect of spermatogenesis. The present invention further relates to a pharmaceutical composition for improving sexual function of male mammals, and/or for providing the effect of spermatogenesis, which comprises at least one active ingredient selected from ginsenoside Rg1, its metabolites ginsenoside Rh1 and Ppt, and a pharmaceutically acceptable excipient.
Public/Granted literature
- US20110034403A1 USE OF GINSENOSIDE RG1, ITS METABOLITES GINSENOSIDE RH1 AND/OR PPT Public/Granted day:2011-02-10
Information query
